Beta blockers ACE inhibitors

Until recently, the cardiotonics and a diuretic were the treatment of choice for HE However, other dragp such as the angiotensin-converting enzyme (ACE) inhibitors, and beta blockers have become the treatment of choice during the last several years. See Figure 39-1 for an example of a method of determining treatment for left ventricular systolic dysfunction. See Chapters 23, 42, and 46 for more information on the beta blockers, ACE inhibitors, and diuretics, respectively. [Pg.358]

The more recent use of aggressive medical therapy with beta blockers, ACE-inhibitors, aspirin, and HMG Co A reductase inhibitors has had a profound benefit on those with coronary artery disease and reduced LVEF. To that end, revascularization still plays an important role in mortality reduction. In the Studies of Left Ventricular Dysfunction (SOLVD) database, CABG does improve survival compared to more modern use of medical therapy, with a 25% mortality risk reduction as well as an intriguing 46% risk reduction of sudden death [91]. This benefit improved as LVEF decreased, thus providing evidence that revascularization may stabilize heart function, reduce abnormal remodeling, and thus reduce the propensity to arrhythmogenicity. [Pg.80]

BETA-BLOCKERS ACE INHIBITORS, ADRENERGIC NEURONE BLOCKERS, ANGIOTENSIN II RECEPTOR ANTAGONISTS t hypotensive effect Additive hypotensive effect may be used therapeutically Monitor BP at least weekly until stable. Warn patients to report symptoms of hypotension (light-headedness, dizziness on standing, etc.)... [Pg.69]

Much research has been conducted on the etiology of valvular dysfunction and the optimal timing for treatment. Pharmacologic treatment of valvular diseases with beta-blockers, ACE inhibitors, angiotensin receptor blockers and HMG-CoA reductase inhibitors can improve symptoms but has not been shown to effectively prolong survival. Thus, the treatment of choice for... [Pg.123]

Beta blockers ACE inhibitors Alpha blockers Angiotensin II receptor antagonists Calcium-channel blockers Dihydrofyridines Calcium-channel blockers Dikiazem Calcium-channel blockers Verapamil Clonidine Ketanserin Vasodilators... [Pg.881]

Beta blockers, diuretics Thiazide diuretics Calcium channel blockers, alpha blockers ACE inhibitors, ARBs... [Pg.254]

Increase dose of diuretics, beta blockers, calcium blocker, ACE inhibitor, A-II blocker, or a combination... [Pg.297]

Diuretic with beta-blocker, added calcium blocker, ACE inhibitor or alpha blocker, or centrally acting sympatholytic... [Pg.297]

If blood pressure still remains high, then the dose of diuretics or beta-blockers is increased or a calcium channel blocker, ACE inhibitor, angrotension II blocker, or combination drug replaces or is added to the treatment plan. [Pg.382]

If blood pressure does not decrease, the patient is given a diuretic with a beta-blocker or a second drug is added such as a calcium chaimel blocker, ACE inhibitor, alpha blocker, or centrally acting sympatholytic. [Pg.382]

However, in some cases combining two or more antihypertensives has led to severe, first-dose hypotension, see Alpha blockers + ACE inhibitors , p.84. Further, life-threatening bradycardia, asystole and sinus arrest can occur when antihypertensives that cause cardiodepression are given together (see beta blockers and diltiazem , (p.840)). [Pg.880]

Alpha blockers ACE inhibitors Beta blockers Calcium-channel blockers Diuretics... [Pg.881]

ACE inhibitors - AT antagonists - Alpha blockers - Beta blockers Isolated syslolic hypertension (older patienls) - Diuretics preferred (generally Thiazides) - Long-acting dihydropyridine calcium channel blocker... [Pg.143]

Diuretics - Beta blockers (non-ISA) - ACE inhibitors (with systolic dysfunction)... [Pg.143]

ACE-I, angiotensin-converting enzyme inhibitor Aid Ant, aldosterone antagonist ARB, angiotensin receptor blocker BB, beta-blocker CCBA, calcium channel blocking agent DirVaso, direct vasodilator. [Pg.22]

ACE Inhibitor Anticonvulsant Beta Blocker Psychoactive Medication etc. — / / / / ... [Pg.28]

For some of these diseases, such as hypertension and heart disease, drugs such as ACE inhibitors and beta-blockers are available for treatment. For some other diseases, such as Alzheimer s disease, more effective drugs have yet to be discovered. For stroke, two late stage (Phase III) trials of NXY-059 and desmoteplase failed to meet the trial criteria. Other clinical trials in progress for ischemic stroke are presented in Table 11.1. [Pg.369]

Masson, S., Masseroh, M., Fiordaliso, F., et al. (1999) Effects of a DA(2)/alpha(2) agonist and a beta(l)-blocker in combination with an ACE inhibitor on adrenergic activity and left ventricular remodeling in an experimental model of left ventricular dysfunction after coronary artery occlusion. J. Cardiovasc. Pharmacol. 34, 321-326. [Pg.176]

Drugs that may be affected by aspirin include ACE inhibitors, acetazolamide, anticoagulants, anticonvulsants (hydantoins, valproic acid), beta blockers, diuretics, methotrexate, NSAIDs, oral hypoglycemics, and uricosuric agents (probenecid, sulfinpyrazone). [Pg.100]

Diuretics or beta blockers-- 2. ACE inhibitors, calcium blockers, alpha-] blockers, alpha-beta blocker ... [Pg.545]

Heart failure-The recommended starting dose is 40 mg twice daily. Up-titrate to 80 and 160 mg twice daily to the highest dose, as tolerated. Consider reducing the dose of concomitant diuretics. The maximum daily dose in clinical trials was 320 mg in divided doses. Concomitant use with an ACE inhibitor and a beta-blocker is not recommended. [Pg.591]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...